Upstream Bio (UPB) Operating Leases: 2024-2025
Historic Operating Leases for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $703,000.
- Upstream Bio's Operating Leases fell 44.34% to $703,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $703,000, marking a year-over-year decrease of 44.34%. This contributed to the annual value of $1.1 million for FY2024, which is N/A change from last year.
- Latest data reveals that Upstream Bio reported Operating Leases of $703,000 as of Q3 2025, which was down 17.20% from $849,000 recorded in Q2 2025.
- In the past 5 years, Upstream Bio's Operating Leases registered a high of $1.3 million during Q3 2024, and its lowest value of $703,000 during Q3 2025.
- Its 2-year average for Operating Leases is $987,400, with a median of $992,000 in 2025.
- Data for Upstream Bio's Operating Leases shows a maximum YoY crashed of 44.34% (in 2025) over the last 5 years.
- Upstream Bio's Operating Leases (Quarterly) stood at $1.1 million in 2024, then plummeted by 44.34% to $703,000 in 2025.
- Its Operating Leases was $703,000 in Q3 2025, compared to $849,000 in Q2 2025 and $992,000 in Q1 2025.